search
Back to results

Maximal Repair Versus Bridging Reconstruction With BioBrace®

Primary Purpose

Rotator Cuff Tears, Bioinductive Implant

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Bridging Reconstruction using BioBrace
Repair
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rotator Cuff Tears focused on measuring shoulder, rotator cuff, clinical outcomes, radiographic outcomes, biomechanics, bridging reconstruction, rotator cuff repair

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: magnetic resonance imaging (MRI) proven diagnosis of a large or massive (> 3cm), two-tendon (supraspinatus and infraspinatus) tear of the shoulder rotator cuff over 18 years of age Exclusion Criteria: glenohumeral osteoarthritis Western Ontario rotator cuff score >60 uncontrolled diabetes (Hgb A1C >7%) pregnant local or systemic infection inability to cooperate with and/or comprehend post-operative instructions MRI proven non-vascular sites poor nutritional state (Alb <30 g/L) cancer paralysis of the shoulder contracture of the shoulder patients unable to provide informed consent for the study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    Repair

    Bridging Reconstruction using BioBrace

    Arm Description

    This group will undergo a rotator cuff repair procedure.

    This experimental group will undergo bridging reconstruction using the bioinductive implant, BioBrace.

    Outcomes

    Primary Outcome Measures

    Radiographic or clinical failure
    The primary outcome measure for this study will be radiographic and/or clinical failure defined as a rotator cuff tear of equal or larger size than at baseline or does not meet WORC score MCID compared to baseline at any follow up

    Secondary Outcome Measures

    Acromiohumeral Distance
    Acromiohumeral distance (AHD) will be measured on pre- and post-operative x-rays.
    Muscle Atrophy
    Using MRI, muscle atrophy will be measured using Warner's classification between groups.
    Fatty Infiltration
    Fatty infiltration using the Goutallier classification will be used and identified
    Healing Rate
    To measure the structural integrity of the surgery, Sugaya method will be used.
    Western Ontario Rotator Cuff Index (WORC)
    WORC will be measured pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    American Shoulder and Elbow Surgeon survey
    American Shoulder and Elbow Surgeon survey will be measured pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    EQ-5D-5L
    EQ-5D-5L for overall health will be measured pre-operatively, and post-operatively at 6-months, 1-year, and 2-years
    Range of motion
    The range of motion, measured in degrees for flexion, extension, abduction, internal, and external rotation will be measured. These are measured and compared pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    Shoulder strength
    The strength of patients flexion, extension, abduction, internal, and external rotation will be measured. These are measured and compared pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    Biomechanics and Muscle Activity
    Pre- and post-operative (1-year) in-vivo biomechanics and electromyography will be compared between groups during a standardized shoulder lifting study in a laboratory based environment.

    Full Information

    First Posted
    July 5, 2023
    Last Updated
    August 22, 2023
    Sponsor
    Nova Scotia Health Authority
    Collaborators
    CONMED Corporation
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05959733
    Brief Title
    Maximal Repair Versus Bridging Reconstruction With BioBrace®
    Official Title
    Maximal Repair Versus Bridging Reconstruction With BioBrace® for the Treatment of Chronic, Massive Rotator Cuff Tears: Clinical, Radiographic, and In-vivo Biomechanical Analysis
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 1, 2023 (Anticipated)
    Primary Completion Date
    July 31, 2027 (Anticipated)
    Study Completion Date
    July 31, 2027 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Nova Scotia Health Authority
    Collaborators
    CONMED Corporation

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to determine if using BioBrace® to reconstruct the gap in the rotator cuff tears lead to better results for patients compared to the traditional maximal repair method. This study will use a variety of clinical, radiographic, and functional outcome measures. Specifically, the researchers will be comparing the re-tear rate, patient reported outcomes, shoulder strength, range of motion, muscle activation, in-vivo biomechanics, and other radiographic outcomes using x-ray and MRI.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Rotator Cuff Tears, Bioinductive Implant
    Keywords
    shoulder, rotator cuff, clinical outcomes, radiographic outcomes, biomechanics, bridging reconstruction, rotator cuff repair

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Masking Description
    Participants will be unaware to the type of surgery that they received. The investigator will not be blinded, however, the individuals assessing the outcomes will be.
    Allocation
    Randomized
    Enrollment
    60 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Repair
    Arm Type
    Active Comparator
    Arm Description
    This group will undergo a rotator cuff repair procedure.
    Arm Title
    Bridging Reconstruction using BioBrace
    Arm Type
    Experimental
    Arm Description
    This experimental group will undergo bridging reconstruction using the bioinductive implant, BioBrace.
    Intervention Type
    Procedure
    Intervention Name(s)
    Bridging Reconstruction using BioBrace
    Intervention Description
    Patients in the reconstruction group will undergo maximal repair with interposition bridging using BioBrace. This technique will follow a previously described technique by the principal investigator with differences allocated to the graft, it's preparation and insertion. The bursa will be debrided, and rotator cuff edged will be shaved down to stable tissue. BioBrace is bioinductive scaffold composed of highly porous type I collagen and bio-resorbable poly (L-lactide) (PLLA) microfilaments, and will be used as the graft in this trial.
    Intervention Type
    Procedure
    Intervention Name(s)
    Repair
    Intervention Description
    Patients in the maximal repair group will undergo a SCOI-row rotator cuff repair with adequate tension as described previously, with recreation of the rotator cable. Briefly, the SCOI-row rotator cuff repair uses one triple loaded suture anchor for each 1.2cm of torn tendon. This technique has been completed in a previous randomized controlled trial.
    Primary Outcome Measure Information:
    Title
    Radiographic or clinical failure
    Description
    The primary outcome measure for this study will be radiographic and/or clinical failure defined as a rotator cuff tear of equal or larger size than at baseline or does not meet WORC score MCID compared to baseline at any follow up
    Time Frame
    2 years
    Secondary Outcome Measure Information:
    Title
    Acromiohumeral Distance
    Description
    Acromiohumeral distance (AHD) will be measured on pre- and post-operative x-rays.
    Time Frame
    2 year
    Title
    Muscle Atrophy
    Description
    Using MRI, muscle atrophy will be measured using Warner's classification between groups.
    Time Frame
    2 year
    Title
    Fatty Infiltration
    Description
    Fatty infiltration using the Goutallier classification will be used and identified
    Time Frame
    2 year
    Title
    Healing Rate
    Description
    To measure the structural integrity of the surgery, Sugaya method will be used.
    Time Frame
    2 year
    Title
    Western Ontario Rotator Cuff Index (WORC)
    Description
    WORC will be measured pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    Time Frame
    Baseline, 6-month, 1-year, 2-years
    Title
    American Shoulder and Elbow Surgeon survey
    Description
    American Shoulder and Elbow Surgeon survey will be measured pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    Time Frame
    Baseline, 6-month, 1-year, 2-years
    Title
    EQ-5D-5L
    Description
    EQ-5D-5L for overall health will be measured pre-operatively, and post-operatively at 6-months, 1-year, and 2-years
    Time Frame
    Baseline, 6-month, 1-year, 2-years
    Title
    Range of motion
    Description
    The range of motion, measured in degrees for flexion, extension, abduction, internal, and external rotation will be measured. These are measured and compared pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    Time Frame
    Baseline, 6-month, 1-year, 2-years
    Title
    Shoulder strength
    Description
    The strength of patients flexion, extension, abduction, internal, and external rotation will be measured. These are measured and compared pre-operatively, and post-operatively and 6-months, 1-year, and 2-years
    Time Frame
    Baseline, 6-month, 1-year, 2-years
    Title
    Biomechanics and Muscle Activity
    Description
    Pre- and post-operative (1-year) in-vivo biomechanics and electromyography will be compared between groups during a standardized shoulder lifting study in a laboratory based environment.
    Time Frame
    Baseline and 2 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: magnetic resonance imaging (MRI) proven diagnosis of a large or massive (> 3cm), two-tendon (supraspinatus and infraspinatus) tear of the shoulder rotator cuff over 18 years of age Exclusion Criteria: glenohumeral osteoarthritis Western Ontario rotator cuff score >60 uncontrolled diabetes (Hgb A1C >7%) pregnant local or systemic infection inability to cooperate with and/or comprehend post-operative instructions MRI proven non-vascular sites poor nutritional state (Alb <30 g/L) cancer paralysis of the shoulder contracture of the shoulder patients unable to provide informed consent for the study
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Sarah Remedios, MSc
    Phone
    9024737626
    Email
    research@drivanwong.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Ivan Wong, MD
    Organizational Affiliation
    Nova Scotia Health Authority, Orthopaedic Surgeon
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Maximal Repair Versus Bridging Reconstruction With BioBrace®

    We'll reach out to this number within 24 hrs